Prolapse; Female

3

Review clinical trials related to Prolapse; Female. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Pragmatic Evaluation of Performance and Safety of the Anchorsure® Transvaginal Device for Surgical Treatment of Apical Prolapse in Women

Pelvic Organ Prolapse affects 50% of parous women, and apical prolapse is one of the most common types of prolapse. Treatment for apical prolapse ranges from observation, non-surgical treatment or surgical repair. An anchoring device can reduce dissection and operative time and is meant to provide strong fixation whilst minimizing potential postoperative pain by avoiding neurovascular injuries. These potential advantages must be evaluated in terms of performance and safety. This cohort study will be on patients undergoing sacrospinous fixation with the Anchorsure® system with a follow-up of 36 months.

Participants needed: 120
Trial details
Age: 50+Biological sex: FemaleType: ObservationalSponsor: Centre Hospitalier Universitaire de NīmesUpdated: Nov 17, 2025Locations: 4
Eligibility criteria

Women with pelvic organ prolapse with leading edge at or beyond the hymen as con... [+3]

Patient taking part or having taken part in a device or drug interventional stud... [+9]

Status: Recruiting

Functional Links Between the Temporomandibular Joint and the Pelvis in Gynecology

1 Recruitment. 2. Collection of written consents for the study. 3. Random assignment to groups with and without intervention. 4. Completion of questionnaires by study participants, postural pattern assessment, temporomandibular joint assessment, and platform assessment. 5\. Performance of visceral therapy in the group with intervention, in the group without intervention placebo. Duration 5 weeks, treatment 1x per week at the same time of day and given day e.g. Mondays only. 6\. Reassessment as in step 4. 7. Data collection, statistical analyses. 8. Interpretation of results for female participants. 9. Preparation of results for scientific publications.

Participants needed: 200
Trial details
Age: 18-60Biological sex: FemaleType: InterventionalSponsor: Poznan University of Physical EducationUpdated: Feb 7, 2025Locations: 1
Eligibility criteria

Written consent to participate in the study. [+1]

No written consent to participate in the study. [+5]

Status: Recruiting

Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment

This is a randomised study in which we compare the effectiveness of three different procedures in mending symptomatic anterior and apical prolapse in patients who are candidates to receive surgery. They will be randomly assigned in a ratio 1:1:1 to three different groups who will have assigned three different kinds of surgery. In the patients of the first group a classic vaginal hysterectomy with anterior colporrhaphy will be practised. Patients who belong to group two will undergo a vaginal hysterectomy followed by placement of an acellular dermal matrix from cadaveric donors (hADM) for anterior reinforcement and sacrospinous fixation with Anchorsure® device (Neomedic trade mark (TM) International, Spain). Finally, patients from group three will have vaginal hysterectomy followed by sacrospinous fixation with Anchorsure® alone . Patients will be followed-up at 4 weeks, 6 months, 12 months and annually till 36 months to evaluate relapses and possible complications.

Participants needed: 90
Trial details
Phase: Phase 2Age: 18-100Biological sex: FemaleType: InterventionalSponsor: Hospital Mutua de TerrassaUpdated: Jan 17, 2025Locations: 1
Eligibility criteria

Women with symptomatic POP with indication of vaginal surgery. [+4]

Women with previous pelvic floor or prolapse surgery [+4]